16 Documents disponibles dans la collection
These guidelines provide the rationale, steps, procedures, roles, and responsibilities for the operation of the EU Early Warning System. They reflect the requirements of Regulation (EC) No 1920/2006 (as amended) and Council Framework Decision 20[...]
This Manual is a joint production by the EMCDDA and the Prevention Standards Partnership, and presents and describes basic and expert level quality standards for drug prevention. The standards cover all aspects of drug prevention work, including[...]
ENGLISH: This handbook has been developed with the primary purpose of providing specific reference material for the European Prevention Curriculum (EUPC) training courses. It also serves to provide a more general introduction to prevention scie[...]
ENGLISH: This document summarises the main issues concerning evaluation in the field of drug policy. Aimed at those managing rather than undertaking drug policy evaluations, the guide acts as an introduction, providing links to the wider litera[...]
Prices are an essential element of the illicit drug market, from both a supply and demand perspective. They are an indicator of drug availability and are an important tool for understanding the workings of drug supply mechanisms. They may also b[...]
Infectious diseases are among the most serious health consequences of injecting drug use and can lead to significant healthcare costs. Injecting drug users are vulnerable to a range of infectious and communicable diseases through a variety of ri[...]
FRANÇAIS : L'EMCDDA cherche à promouvoir des méthodes d'évaluation scientifique dans le champ de la prévention dans le but d'améliorer la qualité des interventions. Les recommandations de ce manuel doivent permettre de comparer les différents [...]
The EMCDDA first published the Guidelines for the evaluation of drug prevention in 1998 to respond to a need expressed by professionals and policymakers to have a tool and stimulus to evaluate prevention interventions in Europe. These guidelines[...]
FRANÇAIS : En octobre 1999 le CHADS (Edimbourg) et l'université d'Amsterdam ont été sollicités dans le cadre de la politique de l'OEDT de mise à disposition d'outils pour les professionnels de la réduction de la demande. Ce projet vise à facil[...]
ENGLISH : The main objective of the guidelines is to provide a European audience with basic information on the options, elements and procedures of drug-related treatment evaluation. The target readership includes professionals working in treat[...]
FRANÇAIS : Comment répondre aux problèmes des héroïnomanes âgés ? Comment lutter contre les décès causés par le fentanyl et ses dérivés extrêmement puissants ? Comment prévenir les risques dus à la consommation d'alcool et de drogues lors des f[...]
This publication provides a practical introduction to the area of quality standards and quality assurance mechanisms and the key steps involved in their implementation in drug services and systems. The primary audience for this guide is those re[...]
This manual provides a step-by-step guide for those involved in planning and managing infectious diseases and drug services, focusing on how to identify barriers to and opportunities for improving provision of HCV testing and access to treatment[...]
This manual compiles basic but evidence-based prevention principles, planning rules and evaluation tips. Additionally, it provides related documentation or references for download; it is hoped that this additional material will be particularly u[...]
OEDT = EMCDDA ; L. MONTANARI ; B. GUARITA ; A. NOOR ; L. WIESSING ; F. GOMES ; D. HEDRICH ; A. PIRONA ; R. SIMON ; J. VICENTE | 2012
RapportFRANÇAIS : L'indicateur de demande de traitement, ou TDI (Treatment Demand Indicator), a été établi en 2000 à partir des travaux du groupe de coopération du Conseil de l'Europe pour la lutte contre l'abus et le trafic de drogues (Groupe Pompido[...]
Historique
